Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model
Metallomics · 2024
DOI: 10.1093/mtomcs/mfae053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metallomics, 2024. Verfasst von Seyed Mostafa Hosseinpour Mashkani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Materials and Devices, School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Sy…. Hauptthemen laut MEDLINE: Alzheimer Disease, Zinc, Iron, Copper. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Technology Sydney, NHMRC, Ames Research Center NASA.
Themen: Demenz
Abstract (Originalsprache)
Transition metals like copper (Cu), iron (Fe), and zinc (Zn) are vital for normal central nervous system function and are also linked to neurodegeneration, particularly in the onset and progression of Alzheimer's disease (AD). Their alterations in AD, identified prior to amyloid plaque aggregation, offer a unique target for staging pre-amyloid AD. However, analysing their levels in the brain is extremely challenging, necessitating the development of alternative approaches. Here, we utilized laser ablation–inductively coupled plasma–mass spectrometry and solution nebulization–inductively coupled plasma–mass spectrometry to quantitatively measure Cu, Fe, and Zn concentrations in the retina and hippocampus samples obtained from human donors (i.e. AD and healthy controls), and in the amyloid precursor protein/presenilin 1 (APP/PS1) mouse model of AD and wild-type (WT) controls, aged 9 and 18 months. Our findings revealed significantly elevated Cu, Fe, and Zn levels in the retina (*P < .05, P < .01, and P < .001) and hippocampus (*P < .05, *P < .05, and *P < .05) of human AD samples compared to healthy controls. Conversely, APP/PS1 mouse models exhibited notably lower metal levels in the same regions compared to WT mice—Cu, Fe, and Zn levels in the retina (**P < .01, *P < .05, and *P < .05) and hippocampus (**P < .01, **P < .01, and *P < .05). The contrasting metal profiles in human and mouse samples, yet similar patterns within each species’ retina and brain, suggest the retina mirrors cerebral metal dyshomoeostasis in AD. Our findings lay the groundwork for staging pre-AD pathophysiology through assessment of transition metal levels in the retina.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomedical Materials and Devices, School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.
- Hyphenated Mass Spectrometry Laboratory, School of Mathematical and Physical Sciences, University of Technology Sydney, Broadway, Sydney, NSW 2007, Australia.
- Synaptic Neurobiology Laboratory, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne 3010, Australia.
- Vision Science Group (Orthoptics Discipline), Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia.
Förderung
- University of Technology Sydney
- NHMRC
- Ames Research Center NASA
- Mason Foundation
- ARC
Zitieren
APA
Hosseinpour Mashkani, S. M., Bishop, D. P., Westerhausen, M. T., Adlard, P. A., & Golzan, S. M. (2024). Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model. Metallomics. https://doi.org/10.1093/mtomcs/mfae053
Vancouver
Hosseinpour Mashkani SM, Bishop DP, Westerhausen MT, Adlard PA, Golzan SM. Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model. Metallomics. 2024. doi:10.1093/mtomcs/mfae053
BibTeX
@article{HosseinpourMashkani2024,
author = {Hosseinpour Mashkani, Seyed Mostafa and Bishop, David P and Westerhausen, Mika T and Adlard, Paul A and Golzan, S Mojtaba},
title = {Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model},
journal = {Metallomics},
year = {2024},
doi = {10.1093/mtomcs/mfae053}
}
EUVIMED